RecruitingNCT06044922

Heart Rate Variability in Early Prediction of a Noxic Brain Injury After Cardiac Arrest


Sponsor

CMC Ambroise Paré

Enrollment

200 participants

Start Date

Oct 23, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Despite advances in post-resuscitation care of patients with cardiac arrest (CA), the majority of survivors who are treated after restoration of spontaneous circulation (ROSC) will have sequelae of hypoxic-ischemic brain injury ranging from mild cognitive impairment to a vegetative state. Early prognostication in comatose patients after ROSC remains challenging. Recent recommendations suggest carrying out clinical and paraclinical tests during the first 72 h after ROSC, to predict a poor neurological outcome with a specificity greater than 95% (no pupillary and corneal reflexes, bilaterally absent N20 somatosensory evoked potential wave, status myoclonus, highly malignant electroencephalography including suppressed background ± periodic discharges or burst-suppression, neuron-specific enolase (NSE) \> 60 µg/L, a diffuse and extensive anoxic injury on brain CT/MRI), but with a low sensitivity due to frequent confounding factors. The heart rate variability (HRV) is a simple and non-invasive technique for assessing the autonomic nervous system function. In patients with a recent myocardial infarction, reduced HRV is associated with an increased risk for malignant arrhythmias or death. In neurology, reduced HRV is associated with a poor outcome in severe brain injury patients and allows to predict early neurological deterioration and recurrent ischemic stroke after acute ischemic stroke. A reduced HRV could be a sensitive, specific and early indicator of diffuse anoxic brain injury after CA. This multicenter prospective cohort study assesses the added value of early HRV (within 24h of ICU admission) for neuroprognostication after cardiac arrest.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Admitted in intensive care unit (ICU) after resuscitation from cardiac arrest (in-hospital or out-of-hospital)
  • Coma (Glasgow score < 8) after ROSC, requiring sedation and targeted temperature management for at least 24h

Exclusion Criteria5

  • Dying patient (Limitation of life support techniques at admission to the ICU)
  • Non-Sinus Rhythm
  • Pregnant or breastfeeding women
  • Patient under protection of the adults (guardianship, curators or safeguard of justice)
  • Opposition by the trusted person or by the patient once he/she wakes up

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICE24-hour Holter monitoring

Holter monitor is fitted within 2h of ICU admission to acquire a 24-hour electrocardiogram recording


Locations(5)

Brest University Hospital

Brest, Brittany Region, France

Nantes University Hospital

Nantes, Pays de la Loire Region, France

Marseille University Hospital

Marseille, Provence-Alpes-Côte d'Azur Region, France

Ambroise Paré - Hartmann Private Hospital Group

Neuilly-sur-Seine, Île-de-France Region, France

Cochin Hospital

Paris, Île-de-France Region, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06044922


Related Trials